Summary
Elevance Health, Inc. (formerly WellPoint, Inc.) issued this 8-K filing on January 8, 2013, to provide an update on its expected 2012 financial results and its outlook for 2013. The company anticipates that its full-year 2012 GAAP net income per share will exceed its previously issued guidance range, largely due to a favorable settlement of a tax matter in the fourth quarter of 2012. Excluding this tax benefit and other specified items, the company expects its adjusted net income per share to be at the high end or slightly above its prior adjusted guidance. Looking ahead to 2013, WellPoint expects relatively stable adjusted net income compared to 2012, with moderate growth anticipated. This outlook includes integration costs associated with the Amerigroup acquisition. The company also anticipates a lower share count in 2013 due to capital deployment activities, which should contribute to earnings per share growth.
Key Highlights
- 1Full-year 2012 GAAP net income per share is expected to exceed the previously guided range of $7.37 to $7.47.
- 2A favorable settlement of a tax matter in Q4 2012 is the primary driver for the increased GAAP net income.
- 3Excluding the tax settlement and other specified adjustments, 2012 adjusted net income per share is anticipated to be near the high end or slightly above the $7.30 to $7.40 guidance.
- 4For 2013, WellPoint expects relatively stable adjusted net income compared to 2012.
- 5Moderate growth in adjusted net income per share is projected for 2013.
- 6The 2013 outlook includes integration costs related to the previously completed Amerigroup acquisition.
- 7The company anticipates a lower share count in 2013 due to capital deployment, supporting EPS growth.